newsfilter
← Latest News
PR Newswire·

Phio Showcases Innovations in Dermatology Cancers at 2023 Dermatology Summit in San Francisco

MARLBOROUGH, Mass., Jan. 6, 2023 /PRNewswire/ -- Phio Pharmaceuticals (NASDAQ:PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune cells more